TBC1D22A-GTSE1 Fusion FISH Probe
The TBC1D22A-GTSE1 Fusion FISH Probe is used to confirm a fusion of the TBC1D22A and GTSE1 genes. The fusion of the TBC1D22A and GTSE1 genes has been associated with Uterine Corpus Endometrial Carcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TBC1D22A-GTSE1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-GTSE1-20-AQAQ | 20 (40 μL) | 200 μL |
|
TBC1D22A Gene Summary
The TBC1 Domain Family Member 22A (TBC1D22A) gene is located on chr22 :47158517-47571342 at 22q13.31.
Gene Name: TBC1 Domain Family Member 22A
Chromosome: CHR22: 47158517 -47571342
Locus: 22q13.31
GTSE1 Gene Summary
The protein encoded by this gene is only expressed in the S and G2 phases of the cell cycle, where it colocalizes with cytoplasmic tubulin and microtubules. In response to DNA damage, the encoded protein accumulates in the nucleus and binds the tumor suppressor protein p53, shuttling it out of the nucleus and repressing its ability to induce apoptosis. [provided by RefSeq, Jul 2008]
Gene Name: G2 And S-phase Expressed 1
Chromosome: CHR22: 46692637 -46726707
Locus: 22q13.31
Gene Diseases
The TBC1D22A GTSE1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|